| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.6 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |